Intercell Usa, Inc.
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1997-01-01
- Employees
- 112
- Market Cap
- -
- Website
- http://www.iomai.com
Clinical Trials
14
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Open-label Study to Assess Immunogenicity and Safety of a Vaccine Enhancement Patch When Administered With 2 Doses of H5N1 Vaccine
- Conditions
- Healthy
- Interventions
- Biological: A/H5N1 AntigenDrug: Vaccine Enhancement Patch
- First Posted Date
- 2011-05-13
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- Intercell USA, Inc.
- Target Recruit Count
- 276
- Registration Number
- NCT01353534
- Locations
- 🇦🇹
Privatklinik Leech, Graz, Austria
🇦🇹Medical University of Vienna, Vienna, Austria
🇦🇹Medizinische Universität Wien, Wien, Austria
Safety and Immunogenicity Study of Traveler's Diarrhea Vaccine Patch
- Conditions
- Diarrhea
- First Posted Date
- 2010-02-12
- Last Posted Date
- 2020-02-10
- Lead Sponsor
- Intercell USA, Inc.
- Target Recruit Count
- 600
- Registration Number
- NCT01067781
- Locations
- 🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸Miami Research Associates, South Miami, Florida, United States
🇺🇸Johnson County Clinical Trials, Lenexa, Kansas, United States
Traveler's Diarrhea (TD) Vaccine Asia Efficacy Study
- Conditions
- Traveler's Diarrhea
- First Posted Date
- 2009-12-29
- Last Posted Date
- 2012-03-14
- Lead Sponsor
- Intercell USA, Inc.
- Target Recruit Count
- 723
- Registration Number
- NCT01040325
- Locations
- 🇩🇪
Belinger Centrum Reise & Tropenmedizin, Berlin, Germany
🇩🇪Tropical Medicine and Bernhard-Nocht Ints, Hamburg, Germany
🇮🇳Dr. Tito's Health Care and Diagnostic Centre, Goa, India
Travelers' Diarrhea (TD) Vaccine Pivotal Efficacy Study
- Conditions
- Travelers' Diarrhea
- First Posted Date
- 2009-10-12
- Last Posted Date
- 2012-03-14
- Lead Sponsor
- Intercell USA, Inc.
- Target Recruit Count
- 2036
- Registration Number
- NCT00993681
- Locations
- 🇩🇪
Berliner Centrum Reise & Tropenmedizin, Berlin, Germany
🇩🇪University Medical Centre Hamburg-Eppendorf, Hamburg, Germany
🇩🇪Ludwig-Maximilians-Universitat Abt. for Infektions and Tropenmedizin, Munchen, Germany
A/H5N1/LT Dose Ranging Study
- Conditions
- Pandemic Influenza
- First Posted Date
- 2009-05-27
- Last Posted Date
- 2021-12-10
- Lead Sponsor
- Intercell USA, Inc.
- Target Recruit Count
- 500
- Registration Number
- NCT00908687
- Locations
- 🇺🇸
Advanced Clinical Research Institute, Anaheim, California, United States
🇺🇸Solano Clinical Research, Vallejo, California, United States
🇺🇸Miami Research Associates, Miami, Florida, United States
- Prev
- 1
- 2
- Next